Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Dermatology Practical & Conceptual
|
November 14, 2025
Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort
Alessandro Giunta, Maria Esposito, Elena Campione, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
Dermatology and Therapy
|
January 23, 2025
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Rheumatology (Oxford, England)
|
October 25, 2023
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients
Michele Maria Luchetti Gentiloni, Valentino Paci, Ilaria Cimaroli, et al.
Dermatology and Therapy
|
May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Maria Concetta Fargnoli, Martina Burlando, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Dermatology Practical & Conceptual
|
November 14, 2025
Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort
Alessandro Giunta, Maria Esposito, Elena Campione, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
Dermatology and Therapy
|
January 23, 2025
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Rheumatology (Oxford, England)
|
October 25, 2023
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients
Michele Maria Luchetti Gentiloni, Valentino Paci, Ilaria Cimaroli, et al.
Dermatology and Therapy
|
May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Maria Concetta Fargnoli, Martina Burlando, et al.
Page
of 6